Ondexxya - direct healthcare professional communication (DHPC)

andexanet alfa
DHPCHuman

Estonian is available via eTranslation, the European Commission's machine translation service.

Translate to Estonian | Important information about machine translation

Programmist

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Dokumendid

Direct healthcare professional communication (DHPC): Ondexxya (andexanet alfa): commercial anti-FXa activity assays are unsuitable for measuring anti-FXa activity following administration of andexanet alfa

English (EN) (151.37 KB - PDF)

Esmakordselt avaldatud:
Vaata

Key facts

Medicine name
Ondexxya
Active substance
andexanet alfa
Therapeutic area (MeSH)
Drug-Related Side Effects and Adverse Reactions
Regulatory outcome
Variation
DHPC type
Safety signal
Human ATC codes
V03AB
Dissemination date

Share this page